Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ADENOFIBROMA”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 703 records · Page 39Linked to original sources
PubMed2001

Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation.

OBJECTIVES: To test prospectively the diagnostic performance of two logistic regression models for calculation of individual risk of malignancy in adnexal tumors (the 'Tailor model' and the 'Timmerman model'), and to compare them to that of 'pattern recognition' (subjective evaluation of the gray-scale ultrasound image and color Doppler ultrasound examination). DESIGN: Consecutive women with a pelvic mass judged clinically to be of adnexal origin underwent preoperative ultrasound examination including color and spectral Doppler examination. The same examination techniques and definitions as those used in the studies in which the logistic regression models had been created were used. The Tailor model was tested in 133 women (35 of whom hada malignancy) and the Timmerman model in 82 women (29 of whom had a malignancy). A subset of 79 women (28 of whom had a malignancy) was used to compare the performance of the Tailor model and the Timmerman model by calculating and comparing the areas under the receiver operating characteristics curves of the two models. Sensitivity and specificity with regard to malignancy were calculated for all three methods. RESULTS: Pattern recognition performed better than the two logistic regression models (sensitivity around 85%, specificity around 90%). Using a risk of malignancy of > 50% to indicate malignancy (as suggested in the original publications), the sensitivity of the Tailor model was 69% and the specificity 88% (n = 133). The corresponding values for the Timmerman model were 62% and 79% (n = 82). The receiver operating characteristics curves showed the two logistic regression models to have similar diagnostic properties (area under the curve, 0.87 vs. 0.84; P = 0.25; n = 79). The diagnostic performance of the mathematical models was much poorer in this study than in those in which the models had been created. CONCLUSION: The poor diagnostic performance of the mathematical models can probably be explained by subtle differences in definitions and examination technique and by differences between the original tumor populations and the study population. For mathematical models to be generally useful, they probably need to be created on the basis of a very large number of tumors, and the variables in the model must be unequivocally defined and the examination technique meticulously standardized.

Adenofibroma↗
PubMed2000

Endometriosis-associated intestinal tumors: a clinical and pathological study of 6 cases with a review of the literature.

This clinicopathologic study of primary Mullerian tumors of the bowel arising in foci of endometriosis is based on six new cases and an analysis of 17 previously reported cases. Varieties of Mullerian tumors occur in the bowel; the most common types are endometrioid carcinoma, followed by various mixed Mullerian tumors and stromal sarcomas. Seventy-eight percent develop in the rectosigmoid colon, the remaining in the cecum or ileum. Those in the latter area tend to be sarcomas or mixed Mullerian tumors. Certain architectural growth characteristics, derived from precursor endometriosis, are common to most endometriosis-associated intestinal tumors (EAITs). Seventy percent of EAITs occur in the outer bowel wall. Transmural tumors tend to form luminal polyps and assume an hourglass shape. Metachronous or synchronous Mullerian tumors occur in 39% of cases. Seventy percent of women with EAITs are in their mid 30s to early 50s. Common presenting symptoms are abdominal or pelvic pain, melena, and an abdominal or pelvic mass. Documented in 26% of patients is a history of prolonged unopposed estrogen therapy. Only 28.5% of cases die of their tumors, but follow-up is less than 5 years in all but 2 patients.

Adenofibroma↗
PubMed1977

[Histological results of lumps excised from the breast after aspiration (author's transl)].

In 614 breasts tumours assumed to be harmless cysts on palpation were aspirated. In 430 cases aspiration was the definitive treatment. In the other 184 cases excision was necessary in order to obtain histology. 11 cysts were radiologically suspect after air filling. In one case excision demonstrated an undifferentiated milk duct carcinoma. 12 cysts had radiologically suspicious areas outside their margins. In 4 cases lobular carcinoma in situ was present. 161 excisions were necessary because no fluid was aspirated at puncture of the tumour. In 10 cases histology showed malignancy: half of these were metastases from a known primary tumour and half were primary breast carcinomas. Out of 17 precancerous states neoplasia could be demonstrated in two cases in addition to papillary and proliferative duct changes. We have classified this neoplasia as lobular carcinoma in situ.

Adenofibroma↗
PubMed1977

[Fibroadenoma of the breast (author's transl)].

Among 412 female patients with fibroadenoma 30 (7.1%) were shown to have considerable epithelial proliferations, 7 (1.7%) carcinoma in situ (n = 4) or carcinoma (n = 3). All patients with carcinoma or carcinoma in situ in the fibroadenoma were older than 40 years of age. Differentiation of coarse or fine granulation of microcalcifications did not improve the accuracy of mammography. In 32% of fibroadenomas with epithelial proliferations similar changes were also found in the adjacent area of the breast whereas only in 8.8% of fibroadenomas without proliferative changes could epithelial proliferation be observed in adjoining areas. With increasing age the risk of carcinomatous degeneration in fibroadenomas rises to 17%. In multiple fibroadenomas only one of them may show carcinomatous changes whereas the others may appear unremarkable. This necessitates excision of all such tumours. In the same way as carcinomas fibroadenomas are most frequently found in the upper outer quadrant of the breast. Total resection including a surrounding layer of healthy tissue remains the treatment of choice.

Adenofibroma↗
PubMed1977

[Percutaneous demonstration of lactiferous ducts in benign breast tumours. The use of contrast in the diagnosis of breast tumours such as fibroadenomas and proliferative mastopathies (author's transl)].

A new method is described which makes it possible to demonstrate the duct system in fibroadenomas and mastopathies by percutaneous injection of contrast. In this way, the pre-operative diagnosis of benign breast tumours can be confirmed. The technique is described and the early results are illustrated.

Adenofibroma↗
PubMed1985

[Improvement of preoperative evaluation of palpable, noncystic processes of the breast by echomammography].

Sonographic examination of the female breast has now been generally accepted as a clinical examination method. 1 719 patients were subjected to echomammography within the framework of a prospective study. Histologically confirmed results were obtained from 496 palpable findings. Basing on these findings, the value of echomammography was developed in respect of preoperative clarification of palpable carcinomas of the breast. X-ray mammography served as reference method. In benign findings, echomammographic accuracy is 73%, whereas the accuracy of x-ray mammography was found to be 58% only. Fibroadenomas were recognised as a benign process by both methods with an equal quota of accuracy (71% and 73%, respectively). 82% of all fibrocystic mastopathy findings which could be localised via palpation, were sonographically graded as benign, whereas mammography classified only 49% as benign cases. This difference is statistically significant (p less than 0.001). Palpable carcinomas wee considered to be malignant via sonography in 91% of the cases (179 out of 197), whereas x-ray mammography yielded a rate of 82% only. The intraoperative T1 stage was established by sonography in 85% of the palpable carcinomas, whereas x-ray mammography yielded a figure of 76% only. These results underline the importance of echomammography in preoperative clarification of palpable carcinomas of the breast.

Adenofibroma↗
PubMed1990

[Analysis of a method for Doppler study of the female breast].

Besides characteristic morphological differences, carcinomas of the breast show remarkable changes of vascularity, which are essential for their enhanced metabolism. High-frequency CW Doppler allows to investigate normal and pathological vascularisation in the breast. In our basic study we examined 200 patients, 37 with breast malignancies (6 non-palpable lesions). 33 of the carcinomas showed pathological vascularisation. In an extended examination procedure we investigated also normal breast vascularisation and compared it with blood flow in lesions. We developed therefrom an easy and rational method which allows physiological blood flow measurements as well as a differentiation of breast lesions within a few minutes' time.

Adenofibroma↗
PubMed1993

[Modern diagnostics of the breast].

A diagnosis of breast cancer as early as possible is most important for a good prognosis. Among previous imaging modalities (mammography, sonography, DSA, thermography, CT) only mammography was able to prove a significant reduction of mortality, but unfortunately only for women above 50 years of age. Magnetic resonance mammography (MRM) is under technical and clinical evaluation for more than 8 years. Special surface coils and a variety of measurement sequences have been tested. By using "dynamic MRM", i.e., the repetitive imaging of the same slices before and at short time intervals after the injection of contrast medium, a high sensitivity (97.3%) and specificity (96.9%) was found in detecting breast cancers of different histology. In this study especially clinically or mammographically difficult cases were included in order to test the efficacy of dynamic MRM. Breast cancer can be proven or excluded with a very high degree of confidence. Conventional mammography had been yielding a vast number of false positive findings. With MRM, therefore, the number of biopsies can be substantially reduced. The remarkable uniformity of the maximum rate of signal enhancement in carcinomas may be explained by the changed vascularisation of malignant tumours based on early tumour angiogenesis. This change in vascularisation can be detected by combining the use of contrast medium with a high contrast sensitive measurement technique. This method seems to be much more reliable than mammographic or sonographic procedures. MRM needs further technical improvements. Since breast cancer is still the most frequent cause of cancer in women in the Western hemisphere, MRM should be used in all cases where is a discrepancy among radiographic, sonographic or clinical findings. However, MRM examinations should be performed only by experienced examiners, since a variety of pitfalls must be avoided.

Adenofibroma↗
PubMed1993

[The echo-dense edge and hyper-reflective spikes: sensitive criteria for malignant processes in breast ultrasound].

At the Department of Gynaecology of the RWTH-Aachen, 110 patients with palpatory and/or mammographic suspect findings were sonographically examined. By using a high resolution 10 MHz-probe with a freely mobile transducer, a new method of differential diagnostic criteria was established, pertaining to the edge of the tumour. The high echogenetic halo and the hyperdense spikes proved to be most important differential diagnostic tools in assessing sonographically suspect tumours.

Adenofibroma↗
PubMed1991

[Doppler ultrasound differentiation of benign and malignant breast tumors].

Before surgery we studied the blood flow in and around 59 breast tumours (35 malignant and 24 benign) and investigated a correlation with the histology. The most decisive factors were the maximum end-diastolic frequency B (probability greater than magnitude of z = 0.0009) and the mean frequency F mean (probability greater than magnitude of z = 0.0017). The maximum systolic frequency A, the resistance index Ri, the diastolic angle W and the pulsatility index Pi showed less significant differences between malignant and benign histological types. In a retrospective survey, we tried to confirm the definitive histology by our Doppler results. In this, we failed in 17.14%--of malignant cases and in 33.33% in the cases of benign tumours.

Abscess↗
PubMed1993

[Signal characteristics of malignant and benign lesions in dynamic 2D-MRT of the breast].

In a retrospective study of 400 dynamic MR examinations of the breast the signal/time ratio of 62 histopathologically correlated lesions (19 benign, 42 malignant) was evaluated. Points of evaluation were initial signal enhancement (1st and 2nd minute), post-initial signal appearance (2nd to 5th minute) and signal distribution (homogeneous, marginal). Based on these criteria, a point system was defined to help in the assessment of lesions in dynamic breast-MR imaging. The overall sensitivity of this method was 95.3%, the specificity to 89.5% and the accuracy to 93.5%. Pitfalls resulted in two cases of non-invasive carcinoma and in two patients with fibroadenoma.

Adenofibroma↗